| For: | Balakumar P. Unleashing the pathological role of epithelial-to-mesenchymal transition in diabetic nephropathy: The intricate connection with multifaceted mechanism. World J Nephrol 2024; 13(2): 95410 [PMID: 38983761 DOI: 10.5527/wjn.v13.i2.95410] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v13/i2/95410.htm |
| Number | Citing Articles |
| 1 |
Tingting Yuan, Hong Wang, Ting Kang, Weihua Wu, Santao Ou. Advancements in the non-invasive diagnosis of renal fibrosis. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1646412
|
| 2 |
Rucui Yu, Ruiying Wu, Tingting Chen, Yan Zhang, Xiangqing Chen. Yiqi Yangyin Tongluo Recipe Alleviates Diabetic Kidney Disease Through AGE-RAGE Signalling Axis. Diabetes, Metabolic Syndrome and Obesity 2025; : 2041 doi: 10.2147/DMSO.S523784
|
| 3 |
Yi Wei Chen, Shan He, Yu Wang, Lian Ying Hu, Qin Kai Chen, Si Yi Liu. Mitochondrial insights: key biomarkers and potential treatments for diabetic nephropathy and sarcopenia. Frontiers in Cell and Developmental Biology 2025; 13 doi: 10.3389/fcell.2025.1596204
|
| 4 |
Lianxiang Duan, Ziyang Liu, Ling Chen, Yiqing Yang, Yenan Fan, Jie Chen, Jing Hu, Xuezhong Gong, Yue Guo. Efficacy and safety of Guben Tongluo formula in treating chronic kidney disease (stage G3): a multicenter randomized controlled clinical trial. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1691637
|
| 5 |
Yan-ni Wang, Xin Wu, Qi-yan Shan, Qiao Yang, Xiao-yong Yu, Jian-hua Yang, Hua Miao, Gang Cao, Ying-yong Zhao. Acteoside-containing caffeic acid is bioactive functional group of antifibrotic effect by suppressing inflammation via inhibiting AHR nuclear translocation in chronic kidney disease. Acta Pharmacologica Sinica 2025; 46(11): 2975 doi: 10.1038/s41401-025-01598-4
|
| 6 |
Junming Huang, Dong Pang, Chenglong Fan, Guanglin Yang, Jinji Chen, Shaohua Chen. Integrative transcriptomic and machine learning analyses identify HDAC9 as a key regulator of mitochondrial dysfunction and senescence-associated inflammation in diabetic nephropathy. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1627173
|
| 7 |
Haojie Liu, Xiadan Xiang, Chengqian Shi, Jiaowei Guo, Ting Ran, Jinglian Lin, Futing Dong, Jie Yang, Hua Miao. Oxidative stress and inflammation in renal fibrosis: Novel molecular mechanisms and therapeutic targets. Chemico-Biological Interactions 2025; 421: 111784 doi: 10.1016/j.cbi.2025.111784
|
| 8 |
Hua Miao, Kai-En Wang, Ping Li, Ying-Yong Zhao. Rhubarb: Traditional Uses, Phytochemistry, Multiomics-Based Novel Pharmacological and Toxicological Mechanisms. Drug Design, Development and Therapy 2025; : 9457 doi: 10.2147/DDDT.S557114
|
| 9 |
Jin Sun, Mengqing Ma, Hao Zhang, Hao Hu, Yuanyuan Liu, Wanwan Zhang, Binbin Pan, Xin Wan. A novel biomarker Ins60/ApoA for predicting diabetic kidney disease in newly diagnosed type 2 diabetes: a pilot study. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1569730
|
| 10 |
Bingxue Qi, Yang Chen, Siyang Chai, Xiaodan Lu, Li Kang. O‐linked β‐N‐acetylglucosamine (O‐GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy. Diabetic Medicine 2025; 42(2) doi: 10.1111/dme.15436
|
